Sun Pharma expects high single-digit top-line growth in FY23 Ruchika Sharma1 Jun 2022 11:00 AM IST"R&D investments are expected to be between 7-8 per cent of sales next year," Shanghvi noted.
Moderna gets back Spikevax marketing rights in Japan Ruchika Sharma1 Jun 2022 10:00 AM ISTIn Japan, Spikevax is indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.
Roche gets USFDA nod for spinal muscular atrophy therapy Evrysdi for babies below 2 months Ruchika Sharma31 May 2022 4:02 PM ISTOf the babies with 2 or 3 copies of the SMN2 gene (n=6), 100% were able to sit after one year of treatment with Evrysdi, 67% could stand and 50% of...
Sanofi Dupixent under USFDA priority review for adults with prurigo nodularis Ruchika Sharma31 May 2022 2:41 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not...
Entod Pharma gets DCGI nod for phase 3 trials of Atropine eye drops Ruchika Sharma31 May 2022 1:27 PM IST"Low-Dose Atropine eye drops is one of the most viable therapeutic option available to slow down the progression of myopia rapidly and improve a...
Jubilant to double US injectable capacity at cost of Rs 1498 crore Ruchika Sharma31 May 2022 11:46 AM ISTThis agreement is in addition to the $92 million filling line expansion announced in November 2021, which will be commercially available by the end of...
Aurobindo Pharma net profit down 28 percent to Rs 576 crore in Q4 Ruchika Sharma31 May 2022 9:00 AM ISTActive pharmaceutical ingredients revenue for the quarter was at Rs 913 crore as against Rs 794.3 crore in the corresponding previous period, it...
North India gets its first Biotech park in Kathua Ruchika Sharma30 May 2022 4:40 PM ISTDr. Jitendra Singh said that the biotechnology park at Kathua has a potential to produce 25 startups in a year which will be among its great...
Novartis Kymriah gets USFDA nod for relapsed or refractory follicular lymphoma Ruchika Sharma30 May 2022 12:19 PM IST"Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings," claims the...
Strides Pharma bags USFDA nod for pain relief drug Ruchika Sharma30 May 2022 11:51 AM ISTThe medicine will be manufactured at the company’s facility at Bengaluru and will be marketed by Strides Pharma Inc. in the US market.
Eisai gets Japanese orphan drug designation for ultrahigh-dose mecobalamin with prospective indication for functional impairment of amyotrophic lateral sclerosis Ruchika Sharma30 May 2022 11:00 AM ISTALS is an intractable, progressive, neurodegenerative disease that results in severe muscle atrophy and weakness in the muscles due to motor neuron...
Venus Remedies records 9.22 percent increase in sales for FY 2021-22 Ruchika Sharma30 May 2022 9:15 AM ISTSpeaking about the company's outlook for the current financial year, he said Venus Remedies would be looking at diversification to enhance its...
